From Biobanking to Personalized Medicine: the journey of the Estonian Biobank
Lili Milani,Maris Alver,Sven Laur,Sulev Reisberg,Toomas Haller,Oliver Aasmets,Erik Abner,Helene Alavere,Annely Allik,Tarmo Annilo,Krista Fischer,Georgi Hudjashov,Maarja Joeloo,Mart Kals,Liis Karo-Astover,Silva Kasela,Anastassia Kolde,Kristi Krebs,Kertu Liis Krigul,Jaanika Kronberg,Karoliina Kruusmaa,Viktorija Kuku_kina,Kadri Koiv,Kelli Lehto,Liis Leitsalu,Sirje Lind,Laura Birgit Luitva,Kristi Lall,Kreete Lull,Kristjan Metsalu,Mait Metspalu,Rene Mottus,Mari Nelis,Tiit Nikopensius,Miriam Nurm,Margit Noukas,Marek Oja,Elin Org,Marili Palover,Priit Palta,Vasili Pankratov,Kateryna Pantiukh,Natalia Pervjakova,Natalia Pujol-Gualdo,Anu Reigo,Ene Reimann,Steven Smit,Diana Sokurova,Nele Taba,Harry-Anton Talvik,Maris Teder-Laving,Neeme Tonisson,Mariliis Vaht,Uku Vainik,Urmo Vosa,Tonu Esko,Raivo Kolde,Reedik Magi,Jaak Vilo,Triin Laisk,Andres Metspalu
DOI: https://doi.org/10.1101/2024.09.22.24313964
2024-09-24
Abstract:Large biobanks have set a new standard for research and innovation in human genomics and implementation of personalised medicine. The Estonian Biobank was founded a quarter of a century ago, and its biological specimens, clinical, health, omics, and lifestyle data have been included in over 800 publications to date. What makes the biobank unique internationally is its translational focus, with active efforts to conduct clinical studies based on genetic findings, and to explore the effects of return of results on participants. In this review we provide an overview of the Estonian Biobank, highlight its strengths for studying the effects of genetic variation and quantitative phenotypes on health-related traits, development of methods and frameworks for bringing genomics into the clinic, and its role as a driving force for implementing personalized medicine on a national level and beyond.
Genetic and Genomic Medicine